##### 



Exhibit 31.2
 CERTIFICATION
  1.
    
    I have reviewed this Annual Report on Form 10-K for the
period ended December 31, 2006 of Adeza Biomedical
Corporation;2.
    
    Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a
material fact necessary to make the statements made, in
light of the circumstances under which such statements
were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and
other financial information included in this report,
fairly present in all material respects the financial
condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are
responsible for establishing and maintaining disclosure
controls and procedures (as defined in Exchange Act Rules
13a-15(e) and 15d-15(e)) and internal control over
financial reporting (as defined in Exchange Act Rules
13a-15(f) and 15d-15(f)) for the registrant and have:
 (a)
    
    designed such disclosure controls
and procedures, or caused such
disclosure controls and procedures
to be designed under our
supervision, to ensure that
material information relating to
the registrant, including its
consolidated subsidiaries, is made
known to us by others within those
entities, particularly during the
period in which this report is
being prepared;(b)
    
    designed such internal control over
financial reporting, or caused such
internal control over financial
reporting to be designed under our
supervision, to provide reasonable
assurance regarding the reliability
of financial reporting and the
preparation of financial statements
fro external purposes in accordance
with generally accepted accounting
principles;(c)
    
    evaluated the effectiveness of the
registrants disclosure controls
and procedures and presented in
this report our conclusions about
the effectiveness of the disclosure
controls and procedures, as of the
end of the period covered by this
report based on such evaluation;
and(d)
    
    disclosed in this report any change
in the registrants internal
control over financial reporting
that occurred during the
registrants most recent fiscal
quarter (the registrants fourth
fiscal quarter in the case of an
annual report) that has materially
affected, or is reasonably likely
to materially affect, the
registrants internal control over
financial reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed,
based on our most recent evaluation of internal control over
financial reporting, to the registrants auditors and the audit
committee of the registrants board of directors (or persons
performing the equivalent function):
 (a)
    
    all significant
deficiencies and
material weaknesses
in the design or
operation of
internal control
over financial
reporting which are
reasonably likely
to adversely affect
the registrants
ability to record,
process, summarize
and report
financial
information; and(b)
    
    any fraud, whether
or not material,
that involves
management or other
employees who have
a significant role
in the registrants
internal controls
over financial
reporting.